Masimo’s patent-infringement cases against Apple over technology that measures the amount of oxygen in the wearer’s bloodstream are pending in a California district court and at a US trade agency.
In two separate complaints in the US District Court for the District of Delaware, the Cupertino, Calif.-based tech giant said Masimo “hastily developed” its W1 watch during the litigation, part of “a more nefarious potential strategy” to bump …